Boston Scientific said Monday that it would expand technical support for the Lumenis Pulse 120H Holmium Laser System based on the MOSES technology and further strengthen its leadership in stone treatment in Korea.According to Boston Scientific, the company has recently enhanced the expertise of its
CHA Biotech said Monday that it has signed a contract development and manufacturing organization (CDMO) agreement with Cell in Cells, a regenerative medicine cell therapies developer, to provide organoid treatment for cartilage diseases.Under the agreement, CHA Biotech will establish a cell bank of
The Korea Research Institute of Bioscience & Biotechnology (KRIBB) said Monday that a joint research team has developed a platform that can quickly detect multiple respiratory viruses in the field.The state-run institute said it will likely be used as a basis for developing diagnostic devices in the
Seoul National University Bundang Hospital (SNUBH) said it would receive the Presidential Commendation for Global Healthcare Achievement in the 14th Global Healthcare & Medical Tourism held at COEX, southern Seoul, from Thursday.The hospital said the presidential citation is related to the global he
NGeneBio, a company specializing in next-generation sequencing-based precision diagnostic platforms, said Wednesday that it has signed a business agreement with Genolution, a molecular diagnostics company."We signed this business agreement to provide NGS (next-generation sequencing) testing services
Philips Korea said Wednesday that it would showcase the company’s broad ultrasound portfolio for clinical settings at the 39th Korea International Medical & Hospital Equipment Show (KIMES 2024) at COEX, southern Seoul, from Thursday to Sunday.The medical field strives to realize precision medicine b
A joint research team of Seoul National University Bundang Hospital (SNUBH) and Sung Kyun Kwan University (SKKU)-Samsung Medical Center (SMC) has released the results of a genetic study on the relationship between creativity and mental disorders.Professor Myung Woo-jae at the Department of Neuropsyc
The Medical Device Industry Promotion Foundation (MEDIF) will hold the “International Joint Cooperation Seminar on Medical Device Technology and Standard Trends in Orthopedics between Korea and Brazil” based on the TC-Linked Cooperation Foundation for Pre-empting International Standards in Medical D
Lunit, a medical artificial intelligence (AI) company, said Monday that it has signed contracts to provide AI image analysis solutions for cancer diagnosis to Chung Shan Medical University in Taiwan and a large hospital in Singapore.The company said that with these contracts, Lunit plans to strength
SK chemicals has received a series of positive ratings from global rating agencies. Notably, the company’s MSCI ratings have been on an upward curve.SK chemicals said Monday that it received an overall AA rating in the 2023 ESG (Environment, Social and Governance) assessment conducted by Morgan Stan
Sanofi Pasteur Korea said it received marketing authorization from the Ministry of Food and Drug Safety (MFDS) for its invasive meningococcal vaccine, MenQuadfi (meningococcal (A, C, Y, W) polysaccharide-TT protein conjugate vaccine) on Wednesday last week.MenQuadfi is a fully liquid vial quadrivale
Samsung Biologics said Tuesday that it has signed a contract manufacturing agreement worth 381.9 billion won ($352.79 million, based on USD/KRW 1,082.90 on Dec. 21, 2017) with Belgium-based UCB. The contract is an extension of a $41.65 million contract signed with the Belgian company in 2017.UCB is
Coreline Soft's AVIEW Aorta has been recognized as an innovative medical device with insurance benefits, broadening its application in emergency medicine and establishing itself as a new source of revenue.On Monday, the medical AI company announced that AVIEW Aorta, a class 3 cardiovascular image de
NGeneBio, a precision diagnostics platform company, has received approval from the Thai Food and Drug Administration (TFDA) to market HLAaccuTest™ All, an in vitro diagnostic medical device based on next-generation sequencing (NGS) technology.It is the fourth NGS-based product approved for registrat
Celltrion said Thursday that it has completed submitting a marketing authorization application for CT-P47, a biosimilar to Actemra (tocilizumab) for treating autoimmune diseases, to the Ministry of Food and Drug Safety (MFDS).Celltrion has applied for the marketing authorization of CT-P47 for the fu
A Korean research team, led by Professor Kim Na-young at the Department of Internal Medicine of Seoul National University Bundang Hospital (SNUBH), analyzed the differences between males and females with stomach cancer positive for the Epstein-Barr virus (EBV), which infects more than 90 percent of
CHA Biotech has launched a study to enhance the anticancer efficacy of its natural killer (NK) cell therapeutic drug by making the most of polymer, a cationic compound.The cationic compounds used in the study are synthetic polymers, in which monomers, molecules with low molecular weight, are repeate
Celltrion once again demonstrated the competitiveness of its Remsima SC at the 2024 European Crohn's and Colitis Organization (ECCO) congress in Stockholm, Sweden, from last Wednesday to Saturday by receiving favorable reviews from overseas medical professionals.At the ECCO, attended by more than 8,
GC Cell has signed an agreement to transfer the processing technology of its flagship anticancer immune cell therapy, Immuncell-LC Injection, to BioCentriq, its U.S. affiliate, and a cell therapy CDMO company.Through this process technology transfer cooperation, GC Cell and Biocentriq expect to prov
JW Shinyak said Monday it has signed a collaborative research agreement with C&C Research Laboratories, a subsidiary of JW Pharmaceutical, to develop innovative anticancer cell therapies.Under the agreement, JW Shinyak will develop a new CAR-NK cell therapy targeting solid tumors with C&C Research L